Webinar for Potential Applicants
PEER program staff held two webinars on November 15. These webinars explained the program's goals and objectives, eligibility requirements, and the application and review process. The presenters also provided background information on global cervical cancer research and implementation activities and answer questions submitted during the webinar by participants. A number of questions were asked and answered, however, here are more Questions and Answers
that the presenters were able to answer after the webinars. A recording of the webinar is available here
and a PDF copy of the PowerPoint presentation is available here
- To accelerate the scale up of more efficient implementation models of integrating CCS&PT with voluntary family planning programs that optimize the uptake and health impact of both in Malawi and Mozambique
- To accelerate the introduction and scale-up of new technologies that will increase the health impact and efficiency of CCS&PT programs
- Local academic institution and/or other local NGO in Mozambique or Malawi with demonstrated expertise in health-related research
- U.S institution, either academic institution or NGO, that is the prime recipient of NIH funding for research and has a current history of working in Mozambique and/or Malawi or has demonstrate a substantial understanding of implementing CCS&PT and voluntary family planning programming in the region and has demonstrated a partnership capable of rapid implementation in the partner country
- If your institution is not based in the United States, Malawi, or Mozambique, you are not eligible to apply as a prime partner of NAS, though your institution could be included as a sub-partner within an application.
- The U.S institution and/or potentially the local partner will also be expected to make sub-awards to one or more additional implementing organizations that have demonstrated capacity to support integrated family planning and CCS&PT in low-income countries in Sub-Saharan Africa.
- Local organizations that do not have expertise in implementation research or U.S or other international organizations that do not receive HHS/NIH funding for research can be part of the application as sub-partners of the prime subawardees, but cannot be prime subawardees.
As noted above, this application must be submitted as a joint application between the local partner and U.S. partner with separate budgets included for each. Both the U.S. institution and the local institution will be prime subawardees of the National Academies. The joint application should present a coherent description of how the activities in each application will complement one another.
The local partner that is a prime subawardee of the National Academies will play a key role in designing, conducting, and analyzing results from implementation research, as well as in helping with real-time translation of results into policy and programs within the country. The U.S. institution that is a prime subawardee will collaborate with the local partner on the research components, including specific activities designed to strengthen the local institution’s research capacity. To ensure efficient implementation, the U.S institution and/or potentially the local partner (if it has a strong track record of managing large implementation projects), will be expected to make subawards to one or more additional implementing organizations that have demonstrated capacity to support integrated family planning and CCS&PT in low-income countries in sub-Saharan Africa, preferably in diverse regions of Malawi or Mozambique. Details of available funding support for these awards are outlined in Section III: Available Funding Support.
As noted earlier, while a substantial proportion of the funding should support implementation research, the majority of funding should be utilized to improve service delivery, including through supporting implementation and scale-up of innovative or improved technologies and approaches. With regard to support for implementation, forming consortia of partners with complementary expertise is encouraged. Such consortia would include one or more NGOs with proven expertise in implementation of new technologies for CCS&PT, local NGOs that support government health facilities, and other implementers that support health facilities operated by the private sector, such as networks of facilities operated by faith- and/or community-based organizations. Opportunities to engage with the for-profit, private sector in a consortium could be explored, including with manufacturers of relevant CCS&PT products or technologies as well as with commercial outlets to reach patients, such as local drug shops or private clinics. Protecting Life in Global Health Assistance (Formerly known as the Mexico City Policy)
On January 23, 2017, a Presidential Memorandum
was issued reinstating the 2001 Presidential Memorandum on the Mexico City Policy for USAID family planning assistance and directing the Secretary of State to implement a plan to extend the requirements of the Mexico City Policy to “global health assistance furnished by all Departments or Agencies.” USAID began implementing the policy, now known as the Protecting Life in Global Health Assistance policy on May 15, 2017, for grants and cooperative agreements that provide global health assistance. The policy requires foreign NGOs to agree, as a condition of receiving global health assistance, that they will not perform or actively promote abortion as a method of family planning and will not provide financial support to any other foreign NGO that conducts such activities. To implement the Protecting Life in Global Health Assistance Policy, USAID issued a new standard provision on May 15, 2017, which is publicly available here: https://www.usaid.gov/sites/default/files/documents/1868/303maa.pdf
. This provision must be included in all new USAID awards that include global health assistance.